Incidentaloma natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
If left untreated, patients with adrenal incidentaloma may progress to develop [[Dyslipidemia]], [[Osteoporosis]], [[Hyperglycemia]], [[Malignant hypertension]], [[Intracranial hemorrhage]], [[Acute coronary syndrome]], [[Aortic dissection]], malignant transformation, and metastasis. Prognosis is usually good in benign adrenal incidentalomas, death is not directly related to the adrenal mass, but to cardiovascular accidents, malignancy, and chronic disorders, as observed in the general population. [[Adrenocortical carcinoma]] (ACC) carries a poor prognosis and is unlike most tumours of the [[Adrenal cortex|adrenal cortex,]] which are [[benign]] ([[adenomas]]) and only occasionally cause Cushing's syndrome.
If left untreated, patients with adrenal incidentaloma may progress to develop [[Dyslipidemia]], [[Osteoporosis]], [[Hyperglycemia]], [[Malignant hypertension]], [[Intracranial hemorrhage]], [[Acute coronary syndrome]], [[Aortic dissection]], [[malignant]] transformation, and [[metastasis]]. Prognosis is usually good in [[benign]] adrenal incidentalomas, death is not directly related to the [[Adrenal mass causes|adrenal mass]], but to [[Cardiovascular Disease|cardiovascular accidents,]] [[malignancy]], and chronic disorders, as observed in the general population. [[Adrenocortical carcinoma]] (ACC) carries a poor prognosis and is unlike most [[tumors]] of the [[Adrenal cortex|adrenal cortex,]] which are [[benign]] ([[adenomas]]) and only occasionally cause [[Cushing's syndrome]].
==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==


===Natural History===
===Natural History===
*The symptoms of adrenal incidentaloma usually develop in the first/ second/ third decade of life, and start with symptoms such as [[weight loss]], [[anorexia]]. [[diabetes]], high incidence of [[vertebral fractures]], [[dyslipidemia]], [[impaired glucose tolerance]] or [[Diabetes mellitus type 2|type 2 diabetes mellitus]], and evidence of [[atherosclerosis]], paroxysmal attacks of [[Hypertension|hypertension,]] [[palpitation]], [[diaphoresis]], [[headache]], [[pallor]], and [[tremor]], [[hypertension]] and [[hypokalemia]].   
*The symptoms of adrenal incidentaloma usually develop in the fifth decade of life, and start with symptoms such as [[weight loss]], [[anorexia]]. [[diabetes]], high incidence of [[vertebral fractures]], [[dyslipidemia]], [[impaired glucose tolerance]] or [[Diabetes mellitus type 2|type 2 diabetes mellitus]], and evidence of [[atherosclerosis]], paroxysmal attacks of [[Hypertension|hypertension,]] [[palpitation]], [[diaphoresis]], [[headache]], [[pallor]], and [[tremor]], [[hypertension]] and [[hypokalemia]].   
*If left untreated, patients with adrenal incidentaloma may progress to develop [[Dyslipidemia]], [[Osteoporosis]], [[Hyperglycemia]], [[Malignant hypertension]], [[Intracranial hemorrhage]], [[Acute coronary syndrome]], [[Aortic dissection]], malignant transformation, and metastasis.
*If left untreated, patients with adrenal incidentaloma may progress to develop [[Dyslipidemia]], [[Osteoporosis]], [[Hyperglycemia]], [[Malignant hypertension]], [[Intracranial hemorrhage]], [[Acute coronary syndrome]], [[Aortic dissection]], [[malignant]] transformation, and [[metastasis]].
*It seems that the majority of masses, classified as benign and non-hypersecreting at diagnosis, subsequently remains hormonally and morphologically unchanged.<ref name="pmid1745970">{{cite journal| author=Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM| title=Incidentally discovered adrenal tumors: an institutional perspective. | journal=Surgery | year= 1991 | volume= 110 | issue= 6 | pages= 1014-21 | pmid=1745970 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1745970  }}</ref>
*It seems that the majority of masses remain hormonally and morphologically unchanged.<ref name="pmid1745970">{{cite journal| author=Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM| title=Incidentally discovered adrenal tumors: an institutional perspective. | journal=Surgery | year= 1991 | volume= 110 | issue= 6 | pages= 1014-21 | pmid=1745970 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1745970  }}</ref>Some cases develop [[mass]] enlargement or [[Adrenal gland|adrenal]] hyperfunction.<ref name="pmid11751069">{{cite journal| author=Barzon L, Fallo F, Sonino N, Boscaro M| title=Development of overt Cushing's syndrome in patients with adrenal incidentaloma. | journal=Eur J Endocrinol | year= 2002 | volume= 146 | issue= 1 | pages= 61-6 | pmid=11751069 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11751069  }}</ref>
 
* Nine precents of cases showed appearance of another [[mass]] in the contralateral [[adrenal gland]].<ref name="pmid9005978">{{cite journal| author=Bondanelli M, Campo M, Trasforini G, Ambrosio MR, Zatelli MC, Franceschetti P et al.| title=Evaluation of hormonal function in a series of incidentally discovered adrenal masses. | journal=Metabolism | year= 1997 | volume= 46 | issue= 1 | pages= 107-13 | pmid=9005978 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9005978  }}</ref>[[Mass]] enlargement was generally limited to 1–2 cm increase in diameter over a period of 1–3 years.
* In a percentage which varies in different series, some cases develop mass enlargement and/or adrenal hyperfunction.<ref name="pmid11751069">{{cite journal| author=Barzon L, Fallo F, Sonino N, Boscaro M| title=Development of overt Cushing's syndrome in patients with adrenal incidentaloma. | journal=Eur J Endocrinol | year= 2002 | volume= 146 | issue= 1 | pages= 61-6 | pmid=11751069 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11751069  }}</ref>
* Reduction or even disappearance of the [[Adrenal mass causes|adrenal mass]] have been reported in up to 40% of adrenal incidentalomas, most often in the case of cystic lesions, hematomas, or adrenal pseudotumors.
* Nine precent of cases showed mass enlargement greater than 1 cm and/or the appearance of another mass in the contralateral adrenal gland.<ref name="pmid9005978">{{cite journal| author=Bondanelli M, Campo M, Trasforini G, Ambrosio MR, Zatelli MC, Franceschetti P et al.| title=Evaluation of hormonal function in a series of incidentally discovered adrenal masses. | journal=Metabolism | year= 1997 | volume= 46 | issue= 1 | pages= 107-13 | pmid=9005978 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9005978  }}</ref>
* Mass enlargement was generally limited to 1–2 cm increase in diameter over a period of 1–3 years.
* The likelihood of malignant transformation at longterm follow-up for masses considered as benign at diagnosis is therefore minimal, and is estimated at one case per 1000 incidentalomas.
* Reduction or even disappearance of the adrenal mass have been reported in up to 40% (mean, 3.6%) of adrenal incidentalomas, most often in the case of cystic lesions, hematomas, or adrenal pseudotumors.


===Complications===
===Complications===
Line 40: Line 36:


===Prognosis===
===Prognosis===
* In the vast majority of patients with apparently benign adrenal incidentalomas, death is not directly related to the adrenal mass, but to cardiovascular accidents, malignancy, and chronic disorders, as observed in the general population.<ref name="pmid9597935">{{cite journal| author=Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB, Ilstrup DM| title=Can adrenal incidentalomas be safely observed? | journal=World J Surg | year= 1998 | volume= 22 | issue= 6 | pages= 599-603; discussion 603-4 | pmid=9597935 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9597935  }}</ref>  
* In the vast majority of patients with apparently [[benign]] [[Adrenal gland|adrenal]] incidentalomas, death is not directly related to the [[Adrenal mass causes|adrenal mass]], but to cardiovascular accidents, [[malignancy]], and chronic disorders, as observed in the general population.<ref name="pmid9597935">{{cite journal| author=Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB, Ilstrup DM| title=Can adrenal incidentalomas be safely observed? | journal=World J Surg | year= 1998 | volume= 22 | issue= 6 | pages= 599-603; discussion 603-4 | pmid=9597935 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9597935  }}</ref>  
* Cardiac disease in 43%, malignancy in 22%, chronic obstructive pulmonary diseases in 11%, Alzheimer’s disease in 6%, cerebrovascular accident in 4%, pneumonia or sepsis in 4%, ruptured abdominal aortic aneurysm in 2.5%, diabetic renal failure in 2.5%, and other causes in 5%. Also in the series reported by Siren et al., including 21 patients with adrenal incidentaloma.
* [[Incidence|Incidences]] of complications are: cardiac disease in 43%, [[malignancy]] in 22%, [[Chronic obstructive pulmonary disease|chronic obstructive pulmonary diseases]] in 11%, [[Alzheimer's disease|azheimer’s disease]] in 6%, [[cerebrovascular accident]] in 4%, [[pneumonia]] or [[sepsis]] in 4%, ruptured [[abdominal aortic aneurysm]] in 2.5%, [[Renal insufficiency|renal failure]] in 2.5%, and other causes in 5%.  
* [[Adrenocortical carcinoma]] (ACC) carries a poor prognosis and is unlike most tumours of the [[Adrenal cortex|adrenal cortex,]] which are [[benign]] ([[adenomas]]) and only occasionally cause Cushing's syndrome.   
* [[Adrenocortical carcinoma]] (ACC) carries a poor prognosis and is unlike most [[tumors]] of the [[Adrenal cortex|adrenal cortex,]] which are [[benign]] ([[adenomas]]) and only occasionally cause [[Cushing's syndrome]].   
* Five-year disease-free survival for a complete resection of a stage I–III ACC is approximately 30%.   
* Five-year disease-free survival after a complete resection of a stage I–III ACC is 30%.   
* The most important prognostic factors are age of the patient, stage of the tumor, mitotic activity, venous invasion, weight of 50g, and diameter of 6.5 cm.
* The most important prognostic factors are:
* The most common causes of death were related to [[cardiovascular diseases]] ([[acute myocardial infarction]], [[Ventricular arrhythmias|ventricular arrhythmia]], [[Congestive heart failure|cardiac failure]], [[multi-infarct dementia]], and [[Cerebral infarction|acute cerebrovascular infarct]]), which occurred in seven out of nine deaths, whereas [[pulmonary embolism]] secondary to [[deep vein thrombosis]] and [[lung cancer]] occurred in two.   
* Age of the patient
* Mean age at death was 72.8 years.   
* [[Cancer staging|Stage]] of the [[tumor]]
* [[Mitotic|mitotic activity]]
* Venous [[invasion]]
* Weight of 50g  
* Diameter of 6.5 cm  
* The most common causes of death were related to [[cardiovascular diseases]] ([[acute myocardial infarction]], [[Ventricular arrhythmias|ventricular arrhythmia]], [[Congestive heart failure|cardiac failure]], [[multi-infarct dementia]], and [[Cerebral infarction|acute cerebrovascular infarct]]).   
* [[Mean]] age at death was 72.8 years.   
* Whether the relatively high [[Mortality rate|rate of mortality]] due to [[Circulatory system|cardiovascular]] disease is related to [[hypercortisolism]] was not investigated.
* Whether the relatively high [[Mortality rate|rate of mortality]] due to [[Circulatory system|cardiovascular]] disease is related to [[hypercortisolism]] was not investigated.



Revision as of 19:15, 25 September 2017

Incidentaloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Incidentaloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Incidentaloma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Incidentaloma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Incidentaloma natural history, complications and prognosis

CDC on Incidentaloma natural history, complications and prognosis

Incidentaloma natural history, complications and prognosis in the news

Blogs on Incidentaloma natural history, complications and prognosis

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Incidentaloma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]

Overview

If left untreated, patients with adrenal incidentaloma may progress to develop Dyslipidemia, Osteoporosis, Hyperglycemia, Malignant hypertension, Intracranial hemorrhage, Acute coronary syndrome, Aortic dissection, malignant transformation, and metastasis. Prognosis is usually good in benign adrenal incidentalomas, death is not directly related to the adrenal mass, but to cardiovascular accidents, malignancy, and chronic disorders, as observed in the general population. Adrenocortical carcinoma (ACC) carries a poor prognosis and is unlike most tumors of the adrenal cortex, which are benign (adenomas) and only occasionally cause Cushing's syndrome.

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

References

  1. Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM (1991). "Incidentally discovered adrenal tumors: an institutional perspective". Surgery. 110 (6): 1014–21. PMID 1745970.
  2. Barzon L, Fallo F, Sonino N, Boscaro M (2002). "Development of overt Cushing's syndrome in patients with adrenal incidentaloma". Eur J Endocrinol. 146 (1): 61–6. PMID 11751069.
  3. Bondanelli M, Campo M, Trasforini G, Ambrosio MR, Zatelli MC, Franceschetti P; et al. (1997). "Evaluation of hormonal function in a series of incidentally discovered adrenal masses". Metabolism. 46 (1): 107–13. PMID 9005978.
  4. Dekkers OM, Horváth-Puhó E, Jørgensen JO, Cannegieter SC, Ehrenstein V, Vandenbroucke JP; et al. (2013). "Multisystem morbidity and mortality in Cushing's syndrome: a cohort study". J Clin Endocrinol Metab. 98 (6): 2277–84. doi:10.1210/jc.2012-3582. PMID 23533241.
  5. Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB, Ilstrup DM (1998). "Can adrenal incidentalomas be safely observed?". World J Surg. 22 (6): 599–603, discussion 603-4. PMID 9597935.

Template:WH Template:WS